品質 GMP factory supply high purity Apraglutide peptide  CAS 1295353-98-8 Apraglutide powder for research 工場
品質 GMP factory supply high purity Apraglutide peptide  CAS 1295353-98-8 Apraglutide powder for research 工場
品質 GMP factory supply high purity Apraglutide peptide  CAS 1295353-98-8 Apraglutide powder for research 工場
品質 GMP factory supply high purity Apraglutide peptide  CAS 1295353-98-8 Apraglutide powder for research 工場

製品概要

Apraglutide (CAS 1295353-98-8) Product Details Apraglutide, with CAS Number 1295353-98-8, is a synthetic, long-acting glucagon-like peptide-2 (GLP-2) agonist, also known as FE 203799. It is a 33-amino acid modified peptide with four amino acid substitutions compared to the native GLP-2, which ...

GMP factory supply high purity Apraglutide peptide CAS 1295353-98-8 Apraglutide powder for research

基本プロパティ

原産地: 武漢
ブランド名: Bovita
認定: DMF
モデル番号: BVR14

取引物件

最低注文数量: 1G
価格: 220USD
標準梱包: PVCボトルまたはアルミホイルバッグ
納期: 3~7日
支払い条件: L/C、D/A、D/P、T/T、ウェスタンユニオン
供給能力: 5kg/月
製品詳細
ハイライト:

GMP Apraglutide peptide powder

,

high purity Apraglutide CAS 1295353-98-8

,

research-grade Apraglutide peptide

Appearence:
Specification: 1g/5g/袋
Stocks: はい
Storage Temp: 2~8℃
Test Method: HPLC HNMR
Color:
Casnumber: ペプチドによって異なります
Puritylevel: 医薬品グレード
Einecs: 1295353-98-8
Lead Time: 支払い後3-5営業日
Product Type: カスタムペプチド
Packagingmaterial: PVCボトルまたはアルミホイルバッグ
Type: GLP-2
製品の説明
詳細な仕様と特徴
Apraglutide (CAS 1295353-98-8) Product Details
Apraglutide, with CAS Number 1295353-98-8, is a synthetic, long-acting glucagon-like peptide-2 (GLP-2) agonist, also known as FE 203799. It is a 33-amino acid modified peptide with four amino acid substitutions compared to the native GLP-2, which enhances its stability and resistance to degradation by dipeptidyl peptidase-4 (DPP-4). As a high-purity peptide hormone, it strictly complies with international pharmaceutical standards (GMP, USP, EP) and is widely used in global medical research, clinical trials and pharmaceutical R&D, especially in the fields of intestinal disorder treatment and gastrointestinal function regulation.

Product Basic Information

Item
Details
CAS Number
1295353-98-8
Product Name
Apraglutide; FE 203799; GLP-2 Analogue
Chemical Formula
C₁₇₂H₂₆₃N₄₃O₅₂
Molecular Weight
Approx. 3765.24
Appearance
White to Off-White Solid Powder
Purity
≥98% (HPLC); ≥99% available for research grade
Solubility
DMSO: ~100 mg/mL (26.56 mM, ultrasonic assistance recommended); Insoluble in Water; Homogeneous suspension in CMC-Na (≥5 mg/mL)
Storage Condition
Sealed, Protected from Light; Powder: -20°C for 3 years, 4°C for 2 years; Dissolved: -80°C for 6 months, -20°C for 1 month; Avoid repeated freeze-thaw cycles and moisture exposure
Shelf Life
36 Months under Proper Storage Conditions (powder)
Peptide Sequence
His-Gly-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Nle-D-Phe-Thr-Ile-Leu-Asp-Leu-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp-NH₂ (HGDGSFSDE-Nle-d-F-TILDLLAARDFINWLIQTKITD-NH₂)

Pharmacological Action & Clinical Applications

Mechanism of Action

Apraglutide acts as a full agonist of the GLP-2 receptor, selectively activating GLP-2 receptors in the gastrointestinal (GI) tract by mimicking the effects of native GLP-2. Its key effects include stimulating intestinal growth, enhancing intestinal fluid and nutrient absorption, promoting intestinal epithelial healing, and improving intestinal barrier integrity and function. Its long-acting property is attributed to its high binding affinity to plasma proteins and resistance to DPP-4 degradation, with a longer half-life compared to other GLP-2 agonists, allowing for less frequent dosing (e.g., once-weekly subcutaneous injection). The incorporation of aminocaproic acid (Ahx) in place of methionine at position 10 further reduces degradation by lysine-targeting proteolytic enzymes, extending its circulating half-life.

Main Clinical Uses

  • Intestinal Disorder Research: Primarily studied for the treatment of short bowel syndrome (SBS), especially short bowel syndrome with intestinal failure (SBS-IF), helping reduce patients’ dependence on parenteral (intravenous) nutrition by improving intestinal absorption capacity.
  • Graft-Versus-Host Disease (GVHD) Research: Investigated for the prevention and treatment of gastrointestinal GVHD, a complication of bone marrow or stem cell transplantation, by enhancing intestinal barrier function and reducing intestinal inflammation.
  • Pharmaceutical R&D: Serves as a key tool for researching the GLP-2 receptor pathway and developing new drugs for intestinal disorders, with ongoing clinical trials evaluating its safety, efficacy, and pharmacokinetics in different patient populations.
  • Animal Model Research: Widely used in animal experiments (e.g., neonatal piglet models of SBS with total ileal resection) to study intestinal adaptation and linear intestinal growth, providing a basis for clinical application research.

Contraindications & Adverse Reactions

Contraindications: Prohibited for patients with hypersensitivity to any component of the product, severe gastrointestinal obstruction, and those with severe hepatic or renal impairment.
Adverse Reactions: Common reactions may include mild gastrointestinal discomfort (nausea, abdominal distension), transient fatigue, and injection site reactions. Long-term use may lead to intestinal hyperplasia and electrolyte disturbances. Regular monitoring of intestinal function, hepatic and renal function, and electrolytes is recommended during use.

Export Compliance & Trade Information

Regulatory Attribute

Apraglutide is classified as a peptide hormone drug in China, subject to the administration of Drug Import and Export License (Regulatory Code: L). It complies with GMP, USP, EP and other international pharmaceutical standards, and meets the regulatory requirements of major global markets such as the EU and the United States, including FDA orphan drug designations for SBS and GVHD treatment, and EU orphan drug designation for SBS treatment.

HS Code & Declaration Elements

Recommended HS Code: 2934999001 (Peptide hormones and their derivatives; subject to the latest customs code of the importing country); For finished dosage forms, refer to HS Code 3004 (Medicaments for therapeutic or prophylactic uses). Note that ECCN (Export Control Classification Number) is distinct from HS Code and should be confirmed based on local regulations for US exports.
Declaration Elements: CAS Number, Product Name, Purity, Usage (Medical/Research), Composition, Brand, Peptide Sequence, Amino Acid Substitution Information, etc.

Export Documentation Requirements

  • Drug Export Sales Certificate (valid for 3 years), issued by the provincial drug regulatory authority of China.
  • Import License or official certification of the importing country (if required), especially complying with FDA regulations for the US market, CEP requirements for the EU market, and EAR requirements for US exports, as well as orphan drug related certifications.
  • Relevant qualifications: GMP Certificate, Production Approval Number, Sales Contract, etc.
  • Test Reports: COA (Certificate of Analysis), MSDS (Material Safety Data Sheet), peptide sequence verification report, purity test report (HPLC/MS), and endotoxin test report (available upon request).

Logistics & Packaging

Packaging: Aluminum foil bag or glass vial, labeled with "Drug, Protect from Light, Keep Dry", peptide sequence and amino acid substitution information; sealed packaging to prevent moisture, contamination and peptide degradation. Vacuum-packed options are available upon request.
Transportation: Ambient temperature shipping is acceptable for short-distance transportation (stable at room temperature for several days during shipping and customs clearance); cold chain transportation (shipping with blue ice) is recommended for long-distance or high-temperature environments to ensure product quality. Avoid extreme temperature changes and repeated freeze-thaw cycles.

Quality Assurance & After-Sales Service

  • Strict Quality Control: Each batch of products undergoes HPLC, MS and peptide sequence verification tests to ensure purity, stability and structural accuracy; endotoxin testing (≤50EU/mg) is available upon request. Single impurity ≤2% and peptide content ≥75.0% are guaranteed for research and medical grade products.
  • Customized Service: We can provide customized packaging and specifications according to customer needs, including small-volume research-grade products (≥99% purity) and large-volume medical-grade products, as well as customized solvent formulation guidance for in vivo and in vitro use.GMP factory supply high purity Apraglutide peptide  CAS 1295353-98-8 Apraglutide powder for research 0
総格付け
5.0
★★★★★
★★★★★
最近の50件のレビューに基づいて
最高
100%
4つ星
0
3つ星
0
2つ星
0
星1つ
0
すべてのレビュー
  • J
    Jack
    Italy Mar 21.2026
    ★★★★★
    ★★★★★
    98% purity , nice
  • E
    Eric
    Germany Mar 20.2026
    ★★★★★
    ★★★★★
    i like the price, cheap
  • A
    A*k
    Poland Mar 3.2026
    ★★★★★
    ★★★★★
    good quality, safety shipment
引用を要求しなさい

オンラインで問い合わせの連絡先フォームをご利用ください. 質問があれば,私たちのチームはできるだけ早く連絡します.

最大5つのファイルがアップロードできます